Functional Assessment of Cardiac Beat Dynamics Under Dynamic Flow: Insights from the Mera Microphysiological System
Nuno Almeida, Veasna Sum-Coffey, Patrick Costello, Conor Madden, Shane DevittiD, Sumir Ramesh Mukkunda, Bhairavi Bengaluru Keshava, Sandra Sunil, Leon G. Riley, Seonaid Deely, Chiara Alessia De Benedictis, Mark Lyons, Finola E. CliffeiD
Abstract
Cardiac rhythm is a critical clinical indicator for cardiac arrhythmias and adverse events during drug toxicity studies. In vivo, cardiomyocyte responses to pharmacological agents occur within minutes and are strongly influenced by dynamic drug delivery through blood flow. However, conventional 2D and 3D static culture systems fail to replicate these fluid flow kinetics, limiting their physiological relevance for assessing beat rate responses. Here, we present Mera, an advanced microphysiological system (MPS) developed by Hooke Bio, designed for high-throughput, long-term culture and functional analysis of 3D cardiac spheroids composed of human induced pluripotent stem cell-derived cardiomyocytes and cardiac fibroblasts. Mera enables dynamic perfusion, allowing investigation of cardiomyocyte beat rates under physiologically relevant flow conditions. The platform supports up to 640 spheroids per run and integrates automated imaging, fluid handling, and user-friendly software, operating under controlled physiological conditions (37{degrees}C, 5% CO2). Flow rates are tunable between 0 and 12.5 mL/min to mimic in vivo environments. Pharmacological testing with verapamil, isoproterenol, calcium chloride, and propranolol demonstrated real-time, reversible modulation of beat rate under flow, including recovery following drug-induced suppression. System variability was comparable to a temperature-controlled reference platform, supporting robust statistical analysis. Dose-response studies yielded IC values consistent with literature, confirming physiological relevance. Collectively, these results demonstrate that Mera provides a reproducible, scalable, and human-relevant platform for cardiac drug testing. By enabling dynamic drug exposure and automated analysis, Mera represents a powerful new approach methodology (NAM) for improving the predictive assessment of cardiac safety and beat-rate modulation drug responses.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 38%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Adaptable pulsatile flow generated by quantitative imaging of stem-cell derived cardiomyocytes for disease modeling
T. Qian, D. A. Gil, … M. C. Skala·bioRxiv·Mar 20, 2020
- Non-invasive quantification of contractile dynamics in cardiac cells, spheroids and organs-on-a-chip using high frequency ultrasound
E. M. Strohm, N. I. Callaghan, … C. A. Simmons·bioRxiv·Jun 28, 2022
- How drugs modulate the performance of the human heart
M. Peirlinck, J. Yao, … E. Kuhl·bioRxiv·Jul 12, 2021
- Development of human iPSC-derived cardiomyocytes-based heart-on-a-chip with customized multi-electrode array for drug-induced cardiotoxicity evaluations
Geonho Choi, Ki‐Suk Kim, … Sungho Ko·bioRxiv·Sep 16, 2025
- OptoDyCE: Automated System for High-Throughput All-Optical Dynamic Cardiac Electrophysiology
Aleksandra Klimas, Jinzhu Yu, … Emilia Entcheva·bioRxiv·Jul 31, 2015
- A microwell cell capture device reveals variable response to dobutamine in isolated cardiomyocytes
J. A. Clark, J. D. Weiss, S. Campbell·bioRxiv·May 15, 2019